ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-6A13837
Home | Market Reports | Health| Nursing
Global Autologous Stem Cell and Non Stem Cell Based Therapies Market Research Report 2023
BUY CHAPTERS

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Research Report 2025

Code: QYRE-Auto-6A13837
Report
June 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fibrocell Science, Inc.
Vericel Corporation
Dendreon Corporation (Sanpower Group)
Caladrius Biosciences Inc
Brainstorm Cell Therapeutics
Regeneus
Genzyme Corporation
Pluristem Therapeutics Inc
U.S. Stem Cell Inc
TiGenix (Takeda)

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market

Autologous Stem Cell and Non-Stem Cell Based Therapies Market

The global market for Autologous Stem Cell and Non-Stem Cell Based Therapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autologous Stem Cell and Non-Stem Cell Based Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Stem Cell and Non-Stem Cell Based Therapies.
The Autologous Stem Cell and Non-Stem Cell Based Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous Stem Cell and Non-Stem Cell Based Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous Stem Cell and Non-Stem Cell Based Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report

Report Metric Details
Report Name Autologous Stem Cell and Non-Stem Cell Based Therapies Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fibrocell Science, Inc., Vericel Corporation, Dendreon Corporation (Sanpower Group), Caladrius Biosciences, Inc., BrainStorm Cell Therapeutics, Regeneus Ltd., Genzyme Corporation, Pluristem Therapeutics Inc, U.S. Stem Cell, Inc, TiGenix (Takeda)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Autologous Stem Cell and Non-Stem Cell Based Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market report?

Ans: The main players in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market are Fibrocell Science, Inc., Vericel Corporation, Dendreon Corporation (Sanpower Group), Caladrius Biosciences, Inc., BrainStorm Cell Therapeutics, Regeneus Ltd., Genzyme Corporation, Pluristem Therapeutics Inc, U.S. Stem Cell, Inc, TiGenix (Takeda)

What are the Application segmentation covered in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market report?

Ans: The Applications covered in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market report are Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Autoimmune Diseases, Others

What are the Type segmentation covered in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market report?

Ans: The Types covered in the Autologous Stem Cell and Non-Stem Cell Based Therapies Market report are Autologous Stem Cell Therapy, Non-Stem Cell Therapy

Recommended Reports

Cell-based Therapies

Cancer and Immunology

Gene and Cell Tools

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous Stem Cell Therapy
1.2.3 Non-Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Neurodegenerative Disorders
1.3.4 Cardiovascular Disease
1.3.5 Autoimmune Diseases
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Perspective (2020-2031)
2.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Growth Trends by Region
2.2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Region (2020-2025)
2.2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Region (2026-2031)
2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Dynamics
2.3.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Trends
2.3.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers
2.3.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges
2.3.4 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue
3.1.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue (2020-2025)
3.1.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue
3.4 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio
3.4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2024
3.5 Global Key Players of Autologous Stem Cell and Non-Stem Cell Based Therapies Head office and Area Served
3.6 Global Key Players of Autologous Stem Cell and Non-Stem Cell Based Therapies, Product and Application
3.7 Global Key Players of Autologous Stem Cell and Non-Stem Cell Based Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Type
4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Type (2020-2025)
4.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2026-2031)
5 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Application
5.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Application (2020-2025)
5.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2020-2031)
6.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025)
6.4 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2020-2031)
7.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025)
7.4 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2020-2031)
8.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2020-2031)
9.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025)
9.4 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2020-2031)
10.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fibrocell Science, Inc.
11.1.1 Fibrocell Science, Inc. Company Details
11.1.2 Fibrocell Science, Inc. Business Overview
11.1.3 Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.1.4 Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.1.5 Fibrocell Science, Inc. Recent Development
11.2 Vericel Corporation
11.2.1 Vericel Corporation Company Details
11.2.2 Vericel Corporation Business Overview
11.2.3 Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.2.4 Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.2.5 Vericel Corporation Recent Development
11.3 Dendreon Corporation (Sanpower Group)
11.3.1 Dendreon Corporation (Sanpower Group) Company Details
11.3.2 Dendreon Corporation (Sanpower Group) Business Overview
11.3.3 Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.3.4 Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.3.5 Dendreon Corporation (Sanpower Group) Recent Development
11.4 Caladrius Biosciences, Inc.
11.4.1 Caladrius Biosciences, Inc. Company Details
11.4.2 Caladrius Biosciences, Inc. Business Overview
11.4.3 Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.4.4 Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.4.5 Caladrius Biosciences, Inc. Recent Development
11.5 BrainStorm Cell Therapeutics
11.5.1 BrainStorm Cell Therapeutics Company Details
11.5.2 BrainStorm Cell Therapeutics Business Overview
11.5.3 BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.5.4 BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.5.5 BrainStorm Cell Therapeutics Recent Development
11.6 Regeneus Ltd.
11.6.1 Regeneus Ltd. Company Details
11.6.2 Regeneus Ltd. Business Overview
11.6.3 Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.6.4 Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.6.5 Regeneus Ltd. Recent Development
11.7 Genzyme Corporation
11.7.1 Genzyme Corporation Company Details
11.7.2 Genzyme Corporation Business Overview
11.7.3 Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.7.4 Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.7.5 Genzyme Corporation Recent Development
11.8 Pluristem Therapeutics Inc
11.8.1 Pluristem Therapeutics Inc Company Details
11.8.2 Pluristem Therapeutics Inc Business Overview
11.8.3 Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.8.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.8.5 Pluristem Therapeutics Inc Recent Development
11.9 U.S. Stem Cell, Inc
11.9.1 U.S. Stem Cell, Inc Company Details
11.9.2 U.S. Stem Cell, Inc Business Overview
11.9.3 U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.9.4 U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.9.5 U.S. Stem Cell, Inc Recent Development
11.10 TiGenix (Takeda)
11.10.1 TiGenix (Takeda) Company Details
11.10.2 TiGenix (Takeda) Business Overview
11.10.3 TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction
11.10.4 TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
11.10.5 TiGenix (Takeda) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Fibrocell Science, Inc.
Vericel Corporation
Dendreon Corporation (Sanpower Group)
Caladrius Biosciences Inc
Brainstorm Cell Therapeutics
Regeneus
Genzyme Corporation
Pluristem Therapeutics Inc
U.S. Stem Cell Inc
TiGenix (Takeda)
List of Tables
 Table 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Autologous Stem Cell Therapy
 Table 3. Key Players of Non-Stem Cell Therapy
 Table 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2020-2025)
 Table 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2026-2031)
 Table 10. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends
 Table 11. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers
 Table 12. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges
 Table 13. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints
 Table 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players (2020-2025)
 Table 16. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2024)
 Table 17. Ranking of Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Autologous Stem Cell and Non-Stem Cell Based Therapies, Headquarters and Area Served
 Table 20. Global Key Players of Autologous Stem Cell and Non-Stem Cell Based Therapies, Product and Application
 Table 21. Global Key Players of Autologous Stem Cell and Non-Stem Cell Based Therapies, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2020-2025)
 Table 25. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2026-2031)
 Table 27. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2020-2025)
 Table 29. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2026-2031)
 Table 31. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Fibrocell Science, Inc. Company Details
 Table 47. Fibrocell Science, Inc. Business Overview
 Table 48. Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 49. Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 50. Fibrocell Science, Inc. Recent Development
 Table 51. Vericel Corporation Company Details
 Table 52. Vericel Corporation Business Overview
 Table 53. Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 54. Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 55. Vericel Corporation Recent Development
 Table 56. Dendreon Corporation (Sanpower Group) Company Details
 Table 57. Dendreon Corporation (Sanpower Group) Business Overview
 Table 58. Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 59. Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 60. Dendreon Corporation (Sanpower Group) Recent Development
 Table 61. Caladrius Biosciences, Inc. Company Details
 Table 62. Caladrius Biosciences, Inc. Business Overview
 Table 63. Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 64. Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 65. Caladrius Biosciences, Inc. Recent Development
 Table 66. BrainStorm Cell Therapeutics Company Details
 Table 67. BrainStorm Cell Therapeutics Business Overview
 Table 68. BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 69. BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 70. BrainStorm Cell Therapeutics Recent Development
 Table 71. Regeneus Ltd. Company Details
 Table 72. Regeneus Ltd. Business Overview
 Table 73. Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 74. Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 75. Regeneus Ltd. Recent Development
 Table 76. Genzyme Corporation Company Details
 Table 77. Genzyme Corporation Business Overview
 Table 78. Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 79. Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 80. Genzyme Corporation Recent Development
 Table 81. Pluristem Therapeutics Inc Company Details
 Table 82. Pluristem Therapeutics Inc Business Overview
 Table 83. Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 84. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 85. Pluristem Therapeutics Inc Recent Development
 Table 86. U.S. Stem Cell, Inc Company Details
 Table 87. U.S. Stem Cell, Inc Business Overview
 Table 88. U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 89. U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 90. U.S. Stem Cell, Inc Recent Development
 Table 91. TiGenix (Takeda) Company Details
 Table 92. TiGenix (Takeda) Business Overview
 Table 93. TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Product
 Table 94. TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025) & (US$ Million)
 Table 95. TiGenix (Takeda) Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Autologous Stem Cell and Non-Stem Cell Based Therapies Picture
 Figure 2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type: 2024 VS 2031
 Figure 4. Autologous Stem Cell Therapy Features
 Figure 5. Non-Stem Cell Therapy Features
 Figure 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Neurodegenerative Disorders Case Studies
 Figure 10. Cardiovascular Disease Case Studies
 Figure 11. Autoimmune Diseases Case Studies
 Figure 12. Others Case Studies
 Figure 13. Autologous Stem Cell and Non-Stem Cell Based Therapies Report Years Considered
 Figure 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region: 2024 VS 2031
 Figure 17. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players in 2024
 Figure 18. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2024
 Figure 20. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2020-2031)
 Figure 22. United States Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2020-2031)
 Figure 26. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2020-2031)
 Figure 34. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2020-2031)
 Figure 42. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2020-2031)
 Figure 46. Turkey Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Fibrocell Science, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 50. Vericel Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 51. Dendreon Corporation (Sanpower Group) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 52. Caladrius Biosciences, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 53. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 54. Regeneus Ltd. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 55. Genzyme Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 56. Pluristem Therapeutics Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 57. U.S. Stem Cell, Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 58. TiGenix (Takeda) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Autologous Stem Cell Based Therapies Market Research Report 2024
Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Wounds Therapy Market Research Report 2024
Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Regenerative Injection Market Research Report 2025
Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tissue Based Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stem Cell Hair Transplant Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Insulin Therapies for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Therapy CMO Market Research Report 2025
Myeloid Cells Targeting Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Graft Versus Host Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Invasive Body Sculpting Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Orthopedic Cell Therapy Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions